RBF Capital, LLC Q2 2022 Filing

Filed August 15, 2022

Portfolio Value

$1.4T

Holdings

525

Report Date

Q2 2022

Filing Type

13F-HR

All Holdings (525 positions)

#StockSharesValue% PortfolioType
501
SLDBSOLID BIOSCIENCES INC
156,900$97.0M0.01%
502
DSWLDESWELL INDS INC
30,000$97.0M0.01%
503
FNHCUSDFEDNAT HLDG CO
300,000$93.0M0.01%
504
DHCDIVERSIFIED HEALTHCARE TR
50,000$91.0M0.01%
505
AMPCO-PITTSBURG CORP
211,652$88.0M0.01%
506
IVCUSDINVACARE CORP
58,453$75.0M0.01%
507
SALMSALEM MEDIA GROUP INC
34,200$73.0M0.01%
508
AKOUOS INC
15,290$72.0M0.01%
509
QTM1EURQUANTUM CORP
30,000$68.0M0.00%
510
TUYATUYA INC
24,800$65.0M0.00%
511
MCHXMARCHEX INC
41,600$55.0M0.00%
512
STTKSHATTUCK LABS INC
13,000$53.0M0.00%
513
ALLTALLOT LTD
10,360$51.0M0.00%
514
TSHATAYSHA GENE THERAPIES INC
13,800$51.0M0.00%
515
CASI PHARMACEUTICALS INC
15,936$46.0M0.00%
516
RGSUSDREGIS CORP MINN
40,401$44.0M0.00%
517
9C0ACANGO INC
18,255$41.0M0.00%
518
OKURRENEO PHARMACEUTICALS INC
14,536$39.0M0.00%
519
EVOLEVOLVING SYS INC
24,496$37.0M0.00%
520
ASMBASSEMBLY BIOSCIENCES INC
14,741$31.0M0.00%
521
XLOXILIO THERAPEUTICS INC
10,072$29.0M0.00%
522
FORTRESS BIOTECH INC
30,000$25.0M0.00%
523
WLMSEURWILLIAMS INDL SVCS GROUP INC
14,000$19.0M0.00%
524
ENGLOBAL CORP
18,915$18.0M0.00%
525
VINCERX PHARMA INC
11,654$15.0M0.00%
PreviousPage 6 of 6